These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8782012)

  • 1. Immunologic and virologic studies in long-term non-progressor HIV infected individuals. NOPHROCO Study Group. Non progressors HIV + Roman cohort.
    Aiuti F; D'Offizi G
    J Biol Regul Homeost Agents; 1995; 9(3):82-7. PubMed ID: 8782012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.
    Candotti D; Costagliola D; Joberty C; Bonduelle O; Rouzioux C; Autran B; Agut H
    J Med Virol; 1999 Jul; 58(3):256-63. PubMed ID: 10447421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long-term non-progressors.
    Tamarit A; Alberola J; Mira JV; Tornero C; Galindo MJ; Navarro D
    J Med Virol; 2004 Nov; 74(3):382-9. PubMed ID: 15368523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
    J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid].
    Soriano V; Martín R; del Romero J; Castilla J; Bru F; Bravo R; Gutiérrez M; Martínez P; Valencia E; García S; Mas A; Moreno V; Laguna F; Rodríguez C; Sabín ML; González-Lahoz J
    Med Clin (Barc); 1996 Dec; 107(20):761-6. PubMed ID: 9019602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An observational study on patients treated or not for acute HIV infection.
    Mussini C; Cozzi-Lepri A; Bedini A; Borghi V; Mongiardo N; Cossarizza A; Esposito R
    J Biol Regul Homeost Agents; 2002; 16(1):79-82. PubMed ID: 12003180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
    J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells.
    Bronke C; Westerlaken GH; Miedema F; Tesselaar K; van Baarle D
    Immunol Lett; 2005 Mar; 97(2):215-24. PubMed ID: 15752561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
    Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
    Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression.
    Martinez V; Costagliola D; Bonduelle O; N'go N; Schnuriger A; Théodorou I; Clauvel JP; Sicard D; Agut H; Debré P; Rouzioux C; Autran B;
    J Infect Dis; 2005 Jun; 191(12):2053-63. PubMed ID: 15897991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors.
    Salgado M; Rallón NI; Rodés B; López M; Soriano V; Benito JM
    Clin Immunol; 2011 May; 139(2):110-4. PubMed ID: 21367666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression.
    Salgado M; López-Romero P; Callejas S; López M; Labarga P; Dopazo A; Soriano V; Rodés B
    Virology; 2011 Mar; 411(1):103-12. PubMed ID: 21239032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors.
    Garbuglia AR; Salvi R; Di Caro A; Cappiello G; Montella F; Di Sora F; Recchia O; Lauria F; Benedetto A
    AIDS; 1996 Jan; 10(1):17-21. PubMed ID: 8924247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.